DSC Equity Fund – Healthcare A

Reference Data

ISIN AT0000A0XMM2
Valor Number 19994591
Bloomberg Global ID
Fund Name DSC Equity Fund – Healthcare A
Fund Provider Dreyfus Söhne & Cie AG, Banquiers Aeschenvorstadt 16 | Postfach
4051 Basel
Schweiz
Phone: +41 61 286 66 66
Web: https://www.dreyfusbank.ch
Fund Provider Dreyfus Söhne & Cie AG, Banquiers
Representative in Switzerland Dreyfus Söhne & Cie AG, Banquiers
Basel
Distributor(s) Dreyfus Söhne & Cie AG, Banquiers
Basel
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Austria
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 213.07 CHF 23.12.2024
Previous Price * 213.88 CHF 20.12.2024
52 Week High * 239.85 CHF 03.09.2024
52 Week Low * 204.37 CHF 29.12.2023
NAV * 213.07 CHF 23.12.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 41,387,253
Unit/Share Assets *** 1,483,683
Trading Information SIX

Performance

YTD Performance +4.26% 29.12.2023
23.12.2024
1 month -4.82% 25.11.2024
23.12.2024
3 months -9.13% 23.09.2024
23.12.2024
6 months -7.85% 24.06.2024
23.12.2024
1 year +3.05% 27.12.2023
23.12.2024
2 years -5.42% 23.12.2022
23.12.2024
3 years -13.53% 23.12.2021
23.12.2024
5 years -2.01% 23.12.2019
23.12.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 6.61%
UnitedHealth Group Inc 6.15%
Johnson & Johnson 6.09%
Novo Nordisk AS Class B 4.32%
Merck & Co Inc 4.24%
Abbott Laboratories 4.21%
AbbVie Inc 3.92%
Regeneron Pharmaceuticals Inc 3.29%
AstraZeneca PLC 2.99%
Amgen Inc 2.99%
Last data update 31.10.2024

Cost / Risk

TER 1.53%
TER date 30.04.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.53%
SRRI ***
SRRI date *** 30.11.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)